MedAccess joins G7 DFIs initiative to prepare for future pandemics

by MedAccess

Combatting antimicrobial resistance with stewardship

by Takhona Hlatshwako, Impact Intern

MedAccess welcomes Cyrus Ardalan to its Board of Directors

by MedAccess

UK improves access to life-saving malaria drugs

From: Foreign, Commonwealth & Development Office and The Rt Hon Andrew Mitchell MP

First published here

MedAccess welcomes rollout of G6PD testing and tafenoquine in Brazil

by MedAccess

Do you speak market shaping? Reflections from the first Global Health Market Shaping conference

by Tristana Perez, Development Impact Executive

Alison Evans and Anil Soni join MedAccess Board

by MedAccess

Keeping impact at the heart of MedAccess’ investment decisions

by MedAccess

Malaria vaccine introduction “a big step forward for global health”

by MedAccess

How do advance market commitments and volume guarantees shape healthcare markets?

by Michelle Teo, Chief Investment Officer, MedAccess

MedAccess congratulates Uganda’s efforts to increase access to HIV self-testing

by MedAccess

Antony Ross OBE appointed Chair of MedAccess Investment Committee

by MedAccess

MedAccess becomes founding partner of G7 initiative for impact investing in health

by MedAccess

Non-communicable diseases: Tailoring our approach to innovative finance

by Mayank Anand

Vice President, Health Markets

Implementing volume guarantees for lifesaving health products

by Evans Mburu

Evans leads on post-execution success of our guarantees. Here he explains how we help to ensure health products reach the people who need them.

MedAccess guarantees help medical innovations reach 530 million people in five years

by MedAccess

MedAccess welcomes Brazilian Government’s commitment to P. vivax malaria elimination efforts

by MedAccess

Building better boardrooms with Violet Mordichai and TheBoardroom Africa

by Willem Verhoofstad, MedAccess Board member

Net gains against malaria: A decades-long battle with insecticide-resistant mosquitos

by Melanie Brooks

Read the story

MedAccess welcomes WHO recommendation for chlorfenapyr-pyrethroid mosquito nets

by MedAccess

One test, two results: How a dual test is tackling HIV and syphilis

by Tristana Perez, Development Impact Executive

Next-generation mosquito net found to be highly effective in second key study

by MedAccess

8 things to know about drug-resistant tuberculosis

by Sandeep Juneja, Senior Vice President, Market Access, TB Alliance

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

by BASF and MedAccess

Five key lessons from our first five years

by MedAccess

Professor Helen Rees appointed MedAccess Board Chair

by MedAccess

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

by MedAccess

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

by MedAccess

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

by MedAccess, Unitaid, CHAI and The Aurum Institute

AVAC, BMGF, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention

by MedAccess and partners

New agreement secures historic US$1 price for HIV self-test

by MedAccess, CHAI and Wondfo

2021 Annual Review: Accelerating impact and preparing for the future

by MedAccess

Global COVID-19 Summit: MedAccess’ commitment to vaccine access

by MedAccess

New partnership to help meet country demand for COVID-19 vaccines

by MedAccess, Gavi, OSF

MedAccess and BASF welcome positive trial results for next-generation mosquito net

by MedAccess

MedAccess welcomes inclusion of COVID-19 assay in Hologic’s Global Access Initiative

by MedAccess

Violet Mordichai joins MedAccess on board apprenticeship programme

by MedAccess

MedAccess welcomes Gavi’s decision to roll out world’s first malaria vaccine

by MedAccess

HIV viral load testing: “If we could test more often, we would”

by Laura Mundy, External Relations Associate

Five things you should know about the new partnership to increase access to dual HIV/syphilis testing

by the Clinton Health Access Initiative

New partnership to increase access to dual rapid testing for syphilis and HIV

by MedAccess, CHAI and SD Biosensor

“I know first-hand the importance of patient-friendly TB treatment”

by MedAccess

The importance of tackling resistance in mosquitos

by Laura Mundy, External Relations Associate

MedAccess welcomes Vicky Johnson as new Chief Financial Officer

by MedAccess

Improving availability of patient-friendly tuberculosis preventive therapy

by MedAccess

New financing agreement boost for malaria vaccine

by MedAccess, GSK and Gavi

Getting new malaria control technologies to communities

by Laura Mundy, External Relations Associate

MedAccess announces extension to guarantee support for UNICEF

by MedAccess

COVID-19 vaccine rollout begins in Ghana using syringes purchased with MedAccess support

by MedAccess

Viral load testing: the key to tackling the HIV epidemic

by Laura Mundy, External Relations Associate

Promising progress but more to do for adolescent girls’ health

by Tristana Perez, Development Impact Executive

MedAccess’ life-changing impact highlighted in first Annual Report

by MedAccess

MedAccess and UNICEF partner for access to COVID-19 supplies

by MedAccess

COVID-19: Changing how we think about finance for global health

by Michael Anderson, Chief Executive Officer

Hema Srinivasan appointed Chief Access Officer

by MedAccess

Cost of next generation mosquito nets almost halved

by MedAccess

Fresh support from CDC Group at Global Fund Replenishment

by MedAccess

Importance of HIV tests in global AIDS fight

by MedAccess

MedAccess support for viral load testing announced

by MedAccess

MedAccess joins G7 DFIs initiative to prepare for future pandemics

Combatting antimicrobial resistance with stewardship

MedAccess welcomes Cyrus Ardalan to its Board of Directors

UK improves access to life-saving malaria drugs

MedAccess welcomes rollout of G6PD testing and tafenoquine in Brazil

Do you speak market shaping? Reflections from the first Global Health Market Shaping conference

Alison Evans and Anil Soni join MedAccess Board

Keeping impact at the heart of MedAccess’ investment decisions

Malaria vaccine introduction “a big step forward for global health”

How do advance market commitments and volume guarantees shape healthcare markets?

MedAccess congratulates Uganda’s efforts to increase access to HIV self-testing

Antony Ross OBE appointed Chair of MedAccess Investment Committee

MedAccess becomes founding partner of G7 initiative for impact investing in health

Non-communicable diseases: Tailoring our approach to innovative finance

Implementing volume guarantees for lifesaving health products

MedAccess guarantees help medical innovations reach 530 million people in five years

MedAccess welcomes Brazilian Government’s commitment to P. vivax malaria elimination efforts

Building better boardrooms with Violet Mordichai and TheBoardroom Africa

Net gains against malaria: A decades-long battle with insecticide-resistant mosquitos

MedAccess welcomes WHO recommendation for chlorfenapyr-pyrethroid mosquito nets

One test, two results: How a dual test is tackling HIV and syphilis

Next-generation mosquito net found to be highly effective in second key study

8 things to know about drug-resistant tuberculosis

BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria

Five key lessons from our first five years

Professor Helen Rees appointed MedAccess Board Chair

MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria

P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing

Partners announce reduced price for patient-friendly tuberculosis preventive treatments

AVAC, BMGF, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention

New agreement secures historic US$1 price for HIV self-test

2021 Annual Review: Accelerating impact and preparing for the future

Global COVID-19 Summit: MedAccess’ commitment to vaccine access

New partnership to help meet country demand for COVID-19 vaccines

MedAccess and BASF welcome positive trial results for next-generation mosquito net

MedAccess welcomes inclusion of COVID-19 assay in Hologic’s Global Access Initiative

Violet Mordichai joins MedAccess on board apprenticeship programme

MedAccess welcomes Gavi’s decision to roll out world’s first malaria vaccine

HIV viral load testing: “If we could test more often, we would”

Five things you should know about the new partnership to increase access to dual HIV/syphilis testing

New partnership to increase access to dual rapid testing for syphilis and HIV

“I know first-hand the importance of patient-friendly TB treatment”

The importance of tackling resistance in mosquitos

MedAccess welcomes Vicky Johnson as new Chief Financial Officer

Improving availability of patient-friendly tuberculosis preventive therapy

New financing agreement boost for malaria vaccine

Getting new malaria control technologies to communities

MedAccess announces extension to guarantee support for UNICEF

COVID-19 vaccine rollout begins in Ghana using syringes purchased with MedAccess support

Viral load testing: the key to tackling the HIV epidemic

Promising progress but more to do for adolescent girls’ health

MedAccess’ life-changing impact highlighted in first Annual Report

MedAccess and UNICEF partner for access to COVID-19 supplies

COVID-19: Changing how we think about finance for global health

Hema Srinivasan appointed Chief Access Officer

Cost of next generation mosquito nets almost halved

Fresh support from CDC Group at Global Fund Replenishment

Importance of HIV tests in global AIDS fight

MedAccess support for viral load testing announced

Our partners

Subscribe to our newsletter